Impact of inflammatory and nutritional parameters on mortality in cardiovascular multimorbidity: a comprehensive

Ziqi Chen1, Aijing Zhu2, Xu Zhu1

  • 1State Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

Frontiers in Nutrition
|December 8, 2025
PubMed

Insights

The systemic inflammation response index (SIRI) is a strong predictor of mortality in patients with cardiovascular multimorbidity (CMM). Higher SIRI levels indicate increased risk for all-cause and cardiovascular death, aiding in risk stratification.

Area of Science:

  • Cardiology
  • Biomarkers
  • Public Health

Background:

  • Cardiovascular multimorbidity (CMM) presents a growing global health challenge, linked to premature mortality.
  • Systemic inflammation is a key factor in cardiometabolic diseases, but its prognostic value in CMM is not fully understood.

Purpose of the Study:

  • To investigate the prognostic implications of inflammatory and nutritional biomarkers in patients with CMM.
  • To identify optimal predictors of mortality and develop predictive models for CMM patients.

Main Methods:

  • Analysis of 1,928 CMM patients from NHANES and 364 from a Chinese cohort.
  • Evaluation of ten inflammatory and nutritional parameters, including the systemic inflammation response index (SIRI).
  • Application of multivariable Cox regression, feature selection techniques, nomograms, and machine learning (ML) models for prediction.

Main Results:

  • SIRI was identified as the strongest independent predictor of all-cause and cardiovascular mortality.
  • Elevated SIRI levels significantly increased mortality risk, with consistent findings across subgroups.
  • Nomograms and ML models, particularly XGBoost, demonstrated high predictive accuracy for mortality.

Conclusions:

  • SIRI serves as a valuable biomarker for mortality risk stratification in CMM patients.
  • Validated nomograms and prediction tools offer practical clinical utility for individualized prognosis.
  • Findings support targeting systemic inflammation and nutrition for improved CMM management.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
617
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
368
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
763
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
521
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296